[1] SUMIYOSHI H, MORI C, FUKE I, et al.Complete nucleotide sequence of the Japanese encephalitis virus genome RNA[J]. Virology, 1987, 161(2):497-510. [2] 曾小凤. 乙型脑炎疫苗的运用与研究进展[J]. 湖北畜牧兽医,2013,34(10):62-63. ZENG X F.Application and research progress of Japanese encephalitis vaccine[J]. Hubei Journal of Animal and Veterinary Sciences, 2013, 34(10):62-63. (in Chinese) [3] SOLOMON T, NI H, BEASLEY D W, et al.Origin and evolution of Japanese encephalitis virus in southeast Asia[J]. Journal of Virology, 2003, 77(5):3091-3098. [4] WANG H Y, TAKASAKI T, FU S H, et al.Molecular epidemiological analysis of Japanese encephalitis virus in China[J]. Journal of General Virology, 2007, 88(Pt 3):885-894. [5] ZHANG J S, ZHAO Q M, GUO X F, et al.Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009[J]. PLoS One, 2011, 6(1):e16418. [6] 朱耐伟,朱勇喆,戚中田. 病毒穿越血脑屏障的两种方式与可能机制[J]. 微生物与感染,2016,11(6):366-373. ZHU N W, ZHU Y Z, QI Z T.Two ways and possible mechanisms of virus crossing the blood-brain barrier[J]. Journal of Microbes and Infections, 2016, 11(6):366-373. (in Chinese with English abstract) [7] CHANG C Y, LI J R, CHEN W Y, et al.Disruption of in vitro endothelial barrier integrity by Japanese encephalitis virus-infected astrocytes[J]. Glia, 2015, 63(11):1915-1932. [8] YUAN L, WU R, LIU H, et al.Tissue tropism and molecular characterization of a Japanese encephalitis virus strains isolated from pigs in southwest China[J]. Virus Research, 2016, 215: 55-64. [9] DIAGANA M, PREUX P M, DUMAS M.Japanese encephalitis revisited[J]. Journal of the Neurological Sciences, 2007, 262(1/2):165-170. [10] KING N J, GETTS D R, GETTS M T, et al.Immunopathology of flavivirus infections[J]. Immunology and Cell Biology, 2006, 85(1):33-42. [11] R{Invalid MML}ŽEK D, SALÁT J, SINGH S K, et al. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8 + T-cells[J]. PLoS One, 2011, 6(5):e20472. [12] MORREY J D, OLEN A L, SIDDHARTHAN V, et al.Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents[J]. Journal of General Virology, 2008, 89(2):467-473. [13] MORRY J D, SIDDHARTHAN V, OLEN A L, et al.Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters[J]. The Journal of Infectious Diseases, 2006, 194(9):1300-1308. [14] HALSTEAD S B, THOMAS S J.Japanese encephalitis: new options for active immunization[J]. Clinical Infectious Diseases, 2010, 50(8):1155-1164. [15] CHARLES H.HOKE M D A N. Protection against Japanese encephalitis by inactivated vaccines[J]. The New England Journal of Medicine, 1988, 319(10):608-614. [16] MONATH T P.Japanese encephalitis vaccines: current vaccines and future prospects[J]. Current Topics in Microbiology and Immunology, 2002, 267(1):105-138. [17] LIU Y, LIN H L, ZHU Q, et al.Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012[J]. Vaccine, 2014, 32(15):1768-1773. [18] KIMURA T, SASAKI M, OKUMURA M, et al.Flavivirus encephalitis: pathological aspects of mouse and other animal models[J]. Veterinary Pathology, 2010, 47(5):806-818. |